1. Home
  2. TCBS vs NSRX Comparison

TCBS vs NSRX Comparison

Compare TCBS & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Texas Community Bancshares Inc.

TCBS

Texas Community Bancshares Inc.

HOLD

Current Price

$16.65

Market Cap

45.0M

Sector

Finance

ML Signal

HOLD

NSRX

Nasus Pharma Ltd. Ordinary Shares

N/A

Current Price

$4.80

Market Cap

53.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCBS
NSRX
Founded
1934
2019
Country
United States
Israel
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.0M
53.5M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TCBS
NSRX
Price
$16.65
$4.80
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$20.50
AVG Volume (30 Days)
1.5K
2.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.21%
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.01
$3.99
52 Week High
$20.00
$9.99

Technical Indicators

Market Signals
Indicator
TCBS
NSRX
Relative Strength Index (RSI) 47.89 47.22
Support Level $15.69 $3.99
Resistance Level $16.69 $6.39
Average True Range (ATR) 0.23 0.42
MACD -0.03 0.04
Stochastic Oscillator 18.92 61.65

Price Performance

Historical Comparison
TCBS
NSRX

About TCBS Texas Community Bancshares Inc.

Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.

About NSRX Nasus Pharma Ltd. Ordinary Shares

Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.

Share on Social Networks: